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Background. In Switzerland, leptospirosis is still considered as a travel-associated disease. After the surprising
diagnosis of leptospirosis in a patient who was initially suspected as having primary human immunodeﬁciency virus
infection, we recognized that acquisition of leptospirosis occurred through recreational activities and we identiﬁed
additional affected individuals.
Methods. Detailed anamnesis, excluding occupational exposure, acquisition abroad, and pet contacts, enabled
us to detect the source of infection and identify a cluster of leptospirosis. Convalescent sera testing was performed to
conﬁrm Leptospira infection. Microscopic agglutination tests were used to determine the infecting serovar.
Results. We identiﬁed a cluster of leptospirosis in young, previously healthy persons. Acquisition of leptospirosis
was traced back to a surﬁng spot on a river in Switzerland (Reuss, Aargau). Clinical presentation was indistinct. Two of
the 3 reported cases required hospitalization, and 1 case even suffered frommeningitis. Serologic tests indicated infection
with the serovar Grippotyphosa in all cases. With the exception of the case with meningitis, no antibiotics were admin-
istered, because leptospirosis was diagnosed after spontaneous resolution of most symptoms. Despite a prolonged period
of convalescence in 2 cases, full recovery was achieved. Recent reports on beavers suffering from leptospirosis in this
region underline the possible water-borne infection of the 3 cases and raise the question of potential wildlife reservoirs.
Conclusions. Insufﬁcient awareness of caregivers, which may be promoted by the missing obligation to report
human leptospirosis, combined with the multifaceted presentation of the disease result in signiﬁcant underdiagnosis.
More frequent consideration of leptospirosis as differential diagnosis is inevitable, particularly as veterinary data suggest
re-emergence of the disease.
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Leptospirosis is considered to be a rare disease in indus-
trialized countries [1, 2]. However, leptospires are exis-
tent worldwide [3], and due to changing recreational
behavior (eg, increasing popularity of adventure racing
[4–7]) and ecological changes (eg, global warming,
heavy rainfalls, and ﬂooding), this disease may also be
on the verge of emerging in industrialized countries [8–
11]. We report a cluster of 3 cases with acquisition of
leptospirosis at the same location during river surﬁng
on a standing wave in Switzerland.
METHODS
Study Participants
Leptospirosis was diagnosed in Case 1 and Case 2 dur-
ing routine clinical work. Based on detailed patient his-
tory of these cases, acquisition of leptospirosis at 1
surﬁng spot was suspected. Contact to Case 3 was en-
abled by the prior 2 cases. All described patients provid-
ed written informed consent before publication.
Leptospira-Speciﬁc Laboratory Analyses
All Leptospira-speciﬁc enzyme immunoassays (EIAs)
were performed with the commercially available kits
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SERION ELISA classic Leptospira IgG and SERION ELISA
classic Leptospira IgM (virion/serion, Würzburg, Germany)
according to manufacturer’s instructions. Microscopic aggluti-
nation tests (MATs) were done at the Bavarian State Ofﬁce for
Health and Food Safety following standard procedure [3].
Microscopic agglutination tests included the serovars (sv)
Australis, Autumnalis, Ballum, Bataviae, Bratislava, Canicola,
Copenhageni, Grippotyphosa, Hardjo, Hebdomadis, Javanica,
Icterohaemorrhagiae, Pomona, Pyrogenes, Saxkoebing, Sejroe,
and Tarassovi. Each month, Leptospira sv are checked by con-
trol sera provided by the Royal Tropical Institute of Amsterdam.
Identical amounts of patient’s serum and live antigen were
mixed and incubated at 20 to 30°C and then assessed by dark
ﬁeld microscopy. An agglutination of at least 50% identiﬁed in
dark-ﬁeld microscopy was found to be positive. Titers of reac-
tive sera were determined by stepwise dilution starting from
1:12.5. A positive threshold of 1:100 was used for all sv.
Case 1
A 33-year-old male without relevant prior medical history re-
ported sudden onset of malaise, fever, myalgia, and headache.
After persistence of these symptoms for 4 days, he turned to a
general practitioner. A viral infection was suspected, and symp-
tomatic treatment with a nonsteroidal anti-inﬂammatory drug
(NSAID) was initiated. Due to worsening of symptoms, he vis-
ited an emergency room of a city hospital on the next day. At
presentation, the patient appeared ill and physical examination
was unremarkable (in particular, there were neither skin ﬁnd-
ings nor conjunctival suffusions). Laboratory results revealed
slightly elevated transaminase levels (alanine aminotransferase
133 U/L [normal range: <50 U/L], aspartate aminotransferase
115 U/L [normal range: <50 U/L]), acute kidney injury (maxi-
mum creatinine 146 µmol/L [normal range: 62–106 µmol/L]),
increased C-reactive protein (maximum 174 mg/L [normal
range: <5.0 mg/L]), slight thrombocytopenia (101 G/L [normal
range: 150–450 G/L]), and leukopenia (2.7 G/L [normal range:
3.6–10.5 G/L]) with lymphopenia (0.5 G/L [normal range: 1.1–
4.5 G/L]). Urine chemistry was noticeable for proteinuria
of approximately 500 mg/day. Because medical history was
remarkable for recent meningitis of his spouse, and given the
clinical presentation of headaches associated with slight photo-
phobia, a lumbar puncture was performed after an unremark-
able cranial computed tomography. Cerebrospinal ﬂuid (CSF)
examination showed a normal cell count and no signs of a func-
tional disorder of the blood-brain barrier. With respect to non-
pathological CSF analysis and absence of meningism in physical
examination, the differential diagnosis meningitis seemed un-
likely. The patient was hospitalized and symptomatic treatment
was continued. Serologic testing for hepatitis viruses A, B, and C
was negative, with exception of positive results for anti-hepatitis
A immunoglobulin (Ig) G, which resulted from prior vaccina-
tion. There was no indication of a recent cytomegalovirus
(CMV) or Epstein-Barr virus (EBV) infection (CMV IgM and
CMV IgG: negative; CMV-polymerase chain reaction (PCR):
negative; EBV IgM: negative; EBV IgG: positive; EBV-PCR:
negative). Polymerase chain reaction of the CSF was negative
for CMV, EBV, herpes simplex virus 1 and 2, and varicella-
zoster virus (VZV). Blood cultures remained without growth.
Abdominal ultrasound demonstrated discrete splenomegaly of
14 cm and no postrenal cause of renal failure.
Repeated human immunodeﬁciency virus (HIV) screening
tests performed with Roche COBAS Combo-Screening were
borderline positive. Symptomatic therapy and intravenous hy-
dration resulted in clinical improvement. The patient left the
hospital after 4 days. Because clinical ﬁndings and laboratory
results were considered compatible with a primary HIV infec-
tion, the patient was referred to the outpatient clinic of the Uni-
versity Hospital Zurich.
For conﬁrmatory reasons, HIV testing was redone using an
Abott Architect Combo-Screening test, HIV-1 plasma RNA-
PCR, testing for p24-Antigen, and a Western blot. All of
these results turned out to be negative, and the diagnosis of pri-
mary HIV infection was discarded.
During the initial hospital stay, leptospirosis was considered
and serologic testing was prompted. With a delay of a few days,
Leptospira EIA reported IgM > 100 U/mL and undetectable IgG
(SERION ELISA classic assays). LeptospiraMAT remained neg-
ative. Because these results were inconclusive, testing was re-
peated after 5 weeks. Leptospira infection was conﬁrmed with
seroconversion (Leptospira IgM 74 U/mL, IgG 19 U/mL) and
a MAT titer of 1:1600 for serovar Grippotyphosa, 1:800 for se-
rovar Australis, and 1:400 for serovar Bratislava (Table 1). The
patient reported full recovery without any sequelae.
After detailed anamnesis, occupational risk factors or acqui-
sition abroad were excluded, but river surﬁng as recreational ac-
tivity was revealed. During this activity, swallowing of water
occasionally occurred. In particular, the patient reported fre-
quent surﬁng, approximately 2 times per week, on a standing
wave of a river in Switzerland (Reuss River in Aargau). He
surfed the last time on this river 7 days before onset of symp-
toms. This surﬁng spot turned out to be the most probable in-
fection source.
Case 2
A 32-year-old female—the spouse of Case 1—without any rel-
evant previous medical history reported sudden onset of mal-
aise and dizziness followed by fever, myalgia, and severe
headache associated with photophobia and phonophobia (∼2
weeks before presentation of Case 1). As symptoms persisted,
despite self-initiated therapy with acetaminophen and NSAIDs,
she visited a general practitioner. A viral syndrome was suspect-
ed, and symptomatic therapy with hydration and analgesia was
continued. Several consultations at the general practitioner en-
sued as symptoms deteriorated, despite successively extended
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analgesic therapy. The patient ﬁnally visited an emergency
room as her headaches became intolerable (6 days after onset
of symptoms). She was subfebrile and appeared ill and an-
guished; at clinical examination, meningism was present. Crani-
al computed tomography identiﬁed no intracranial bleeding, no
sinus venous thrombosis, or mass lesions. Laboratory analysis
revealed moderately increased C-reactive protein (19 mg/L
[normal range: <5.0 mg/L]) and slightly elevated alkaline phos-
phatase (132 U/L [normal range: 40–130 U/L]). Transaminases,
creatinine, and white blood count (WBC) were within the
normal range. Lumbar puncture yielded an elevated cell count
(196/µL [normal range: <6/µL]) with a predominance of neu-
trophils and elevated CSF proteins (0.86 g/L [normal range:
0.23–0.38 g/L). Empiric therapy with acyclovir and ceftriaxone
was initiated. Immediately after application of the ﬁrst dose of
ceftriaxone, redness, swelling, and hyperthermia of the extrem-
ities occurred. Because her anamnesis included a penicillin
allergy, an allergic reaction to ceftriaxone was suspected and
steroids and antihistamines were administered once. A viral
pathogenesis of the meningitis was favored, and antibiotic ther-
apy was consequently discontinued. Because adenovirus-PCR,
CMV-PCR, herpes simplex-PCR and VZV-PCR turned out to
be negative, acyclovir was also stopped. Blood and liquor cul-
tures showed no bacterial growth. After 1.5 weeks, the patient
left the hospital still requiring analgesic combination therapy
with metamizole and oxycodone for her headaches. After a pe-
riod of clinical improvement lasting ∼1 week, she suffered from
progressive malaise, relapsing headaches, and nausea, necessi-
tating again admission to a hospital. Since by this time her part-
ner was suspected of suffering from leptospirosis, she was also
tested for Leptospira infection. Leptospira antibodies were
detected by EIA (IgM 84 U/mL, IgG > 100 U/mL; SERION
ELISA classic assays), and MAT conﬁrmed infection by the
serovar Grippotyphosa (titer 1:800 for serovar Grippotyphosa,
1:100 for serovar Australis). Due to the severity of symptoms,
antibiotic therapy with doxycycline was administered. She expe-
rienced progressive improvement within a few days after initia-
tion of therapy, but overall recovery was slow.
Similar to Case 1, this patient reported surﬁng on the same
river twice weekly. She remembered the last exposure to river
water 2 days before symptom onset. No occupational exposure
or contacts with pets existed, and her last stay abroad was more
than 1.5 months before illness. In consideration of the maxi-
mum incubation period of 30 days, acquisition of leptospirosis
most likely occurred in the identical river where her spouse con-
tracted the infection.
We discussed with Cases 1 and 2 our suspicion that surﬁng
on this certain river was the source of infection. Subsequently,
they asked their peer group of river surfers whether they had
any symptoms suggestive of leptospirosis and were able to iden-
tify at least 1 more affected person (ie, Case 3).
Case 3
Case 3 is a 34-year-old male who belongs to the peer group of
the previously described couple. He reported the onset of illness
approximately 1 month before Case 2. He also had no relevant
medical history. Symptoms started with malaise, arthralgia,
fever, and chills. High fever persisted despite regular intake of
acetaminophen. Due to illness, he remained in bed most of
the time. After 4 days of illness, he sought medical attention
at an emergency room. At presentation, he appeared in a slight-
ly reduced general condition, and his vital parameters were
within normal range with exception of a body temperature of
37.9°C. His physical examination was unremarkable. Laborato-
ry results revealed a slightly elevated creatinine (110 µmol/L
[normal range: 62–106 µmol/L]), mild hyponatremia (133
Table 1. Results of Leptospira Serology of Cases 1–3
Serologic Test Case 1 Case 2 Case 3
Leptospira IgMa Initial: >100 U/mL
Convalescent: 74 U/mL
84 U/mLb Initial: 69 U/mL
Convalescent: 29 U/mL
Leptospira IgGa Initial: <10 U/mL
Convalescent: 19 U/mL
>100 U/mL Initial: <10 U/mL
Convalescent: 11 U/mL
Leptospira MATc Initial: not reactive for all tested sv
convalescent:
sv Grippotyphosa 1:1600
sv Australis 1:800
sv Bratislava 1:400
sv Grippotyphosa 1:800b
sv Australis 1:100b
Initial: ND
Convalescent:
sv Grippotyphosa 1:800
Leptospira complement fixation Initial: ND
Convalescent: 1:80
1:120b Initial: ND
Convalescent: 1:120
Abbreviations: ELISA, enzyme-linked immunosorbent assay; Ig, immunoglobulin; MAT, microscopic agglutination tests; ND, not done; sv, serovars.
a SERION ELISA classic assay (virion/serion, Würzburg, Germany).
b Serology only performed at second presentation.
c MAT was performed for sv Australis, Autumnalis, Ballum, Bataviae, Bratislava, Canicola, Copenhageni, Grippotyphosa, Hardjo, Hebdomadis, Javanica,
Icterohaemorrhagiae, Pomona, Pyrogenes, Saxkoebing, Sejroe, and Tarassovi (dilution of 1:100 used as cutoff for all sv, only titers of reactive sv are reported in
Table 1).
Leptospirosis Acquired Through River Surﬁng • OFID • 3
 at U
niversitÃ¤t Bern Volkswirtschftliches Institut on February 11, 2016
http://ofid.oxfordjournals.org/
D
ow
nloaded from
 
mmol/L [normal range: 135–145 mmol/L]), elevated total bilir-
ubin (61 µmol/L [normal range: <21 µmol/L]), and increased
C-reactive protein (74 mg/L [normal range: <5.0 mg/L]).
His blood count was remarkable for mild thrombocytopenia
(97 G/L [normal range: 150–450 G/L]) and left shift (total
WBC within the normal range). Because the patient reported
holidays in Indonesia 3 months earlier, malaria was ruled out
after repeated testing. Blood cultures were negative. Serologic
testing for HIV, viral hepatitis, schistosomiasis, amebas, and ﬁl-
ariasis showed no signs of infection. Again, a viral syndrome
was suspected and symptomatic treatment continued. After 1
week, symptoms started to wane. Subsequently, the patient suf-
fered from severe headaches associated with phonophobia and
photophobia, fever reappeared, and scrotal pain with swelling
was present. This time, symptoms persisted for 1 week and
ended with a gradual weakening of illness. The patient arranged
for an appointment with an Infectious Diseases specialist be-
cause he mistrusted the diagnosis of a viral infection. At consul-
tation, physical examination was unremarkable, but the patient
reported almost full recovery at that time. Differential blood
count, creatinine, transaminases, bilirubin, and C-reactive pro-
tein were within the normal range. Serologic testing revealed el-
evated Leptospira IgM (69 U/mL) with absence of Leptospira
IgG (SERION ELISA classic assays). Leptospirosis was favored,
and because the patient felt healthy again, no treatment was ini-
tiated. Overall, symptoms lasted for approximately 1 month.
Convalescent sera testing veriﬁed leptospirosis caused by sero-
var Grippotyphosa (IgM 29 U/mL, IgG 11 U/mL, MAT 1:800
for serovar Grippotyphosa).
Also in this case, no occupational exposure was present. This
patient had been surﬁng on the suspect river in high frequency
(approximately 4 times per week) for approximately 6 weeks be-
fore onset of illness. The last exposure to river water was report-
ed 3 days before appearance of initial symptoms.
DISCUSSION
To our knowledge, this case series is the ﬁrst cluster of leptospi-
rosis associated with surﬁng on a river in Switzerland. In 2012, a
single case of leptospirosis was traced back to the same river and
even to the identical surﬁng spot [12]. This 28-year-old male
presented with sudden onset of fever, chills, headaches, myalgia,
and arthralgia; laboratory examinations were remarkable for
signs of inﬂammation, acute renal failure, and elevated transam-
inases. In consideration of a bacterial infection, this patient re-
ceived antibiotic therapy with cephalosporines, resulting in
rapid clinical and laboratory improvement. In this case, MAT
identiﬁed an infection with Leptospira serovar Bratislava. It
seems likely that more undiagnosed persons acquired leptospi-
rosis through surﬁng on this river. A 4th case of leptospirosis
was suspected, because another surfer mentioned that he had
also suffered from a prolonged period of compatible clinical
ﬁndings. However, this person refused to undergo a detailed in-
terview and serological testing at our outpatient clinic.
Leptospirosis is a worldwide zoonosis. In addition, leptospi-
rosis is still often considered to be a disease of tropical and sub-
tropical regions and to occur generally in resource-limited
settings, but leptospirosis also occurs in resource-rich settings.
Switzerland lacks an adequate surveillance system for this dis-
ease because human cases are not subjected to mandatory re-
port for more than 15 years. Data from Europe indicated that
the highest rates of leptospirosis occur in summer and fall
[13, 14]. Likewise, all described patients in this study suffered
from leptospirosis either in summer (Case 2 in September
2014, Case 3 in August 2014) or in fall (Case 1 in October
2014). This seasonal pattern may reﬂect the fact that survival
of leptospires depends on warm and humid conditions or that
the risk of acquisition grows with increasing human water activ-
ities during hot summer days. Indeed, mean water temperature,
recorded at an observation station approximately 6 miles down-
stream (Mellingen, Switzerland), was higher in these months
(18.4°C in August 2014, 17.8°C in September 2014, 15.3°C in
October 2014) than the annual average (12.7°C) [15].
Infection of humans occurs via skin lesions, mucous mem-
branes, and less frequently via inhalation or ingestion. In our
case series, infection may have resulted from swallowing water
or macerated or abraded skin during surﬁng [5, 16], but none of
the reported cases remembered having had skin lesions. Several
risk groups due to occupational exposure have been identiﬁed
for leptospirosis, including, for example, farmers, veterinarians,
butchers, and pet sellers, but there is also increasing evidence
for recreational exposure [4–7, 17, 18]. For physicians, the asso-
ciation between recreational activity and leptospirosis may not
be well known, which can result in signiﬁcant underdiagnosis of
leptospirosis. With changes in recreational activities, such as the
growing popularity of extreme sports and adventure racing, an
increase in risk for acquisition of leptospirosis is imaginable.
This hypothesis is also supported by data from the Netherlands
that indicated a high proportion of acquisition of leptospirosis
during recreational activities for both autochthonous and im-
ported infections [19]. The incubation period typically lasts
5–14 days. Given the high frequency of river surﬁng for all re-
ported cases (2–4 times/week), we were not able to identify the
most probable date of acquisition. The severity of the disease
encompasses asymptomatic disease to fatal fulminant infection
[20]. The clinical course is often biphasic and characterized by
an acute phase with fever, headache, myalgia, abdominal pain,
and an immunogenic phase, which may be associated with se-
vere disease manifestations. Initially, all cases suffered from un-
speciﬁc malaise, myalgia or arthralgia, and fever, which was
misinterpreted as viral syndrome. Two of the 3 cases displayed
reworsening of symptoms after a short period of improvement,
only Case 1 described a continuous deterioration. Meningeal in-
volvement presenting as aseptic meningitis (shown in Case 2)
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has recently been reported at a frequency of 5%, and older data
have documented even higher rates [21, 22]. Consistent with
literature, the 2 cases with bimodal presentation experienced
reappearance of subfebrile temperatures or fever during the
immunogenic phase. Severe manifestations encompass Weil’s
disease (characterized by icterus, acute renal failure, bleeding
disorders), renal failure, leptospirosis-associated pulmonary
hemorrhage syndrome, and, rarely, myocarditis [22–25]. Diag-
nosis is complicated by protean symptoms and several difﬁcul-
ties of diagnosis. Despite several limitations, MAT is considered
as reference serologic test method [11]. The MAT is limited to
few expert laboratories because this test requires living lepto-
spires. A MAT performed in the early course of leptospirosis
can deliver negative results and may take up to 3–4 weeks to
become reactive [26, 27]. This is compatible with the initial neg-
ative MAT in Case 1, which developed reactivity in the conva-
lescent sample. Positive MAT results to multiple sv are likely
due to frequent cross-reactions between sv [3, 21] (Table 1).
Nevertheless, the highest titers were recorded for serovar Grip-
potyphosa in all 3 cases, thus indicating that all patients were
infected by the same serovar and likely at the same infection
source. Leptospira-speciﬁc EIAs are approved for diagnostics,
but positive results need to be conﬁrmed by MAT. Culture re-
quires specialized culture media, and it is insensitive and time-
consuming. In addition, culture might remain without growth
due to unspeciﬁc media used at ﬁrst choice; also, in this case
series, unspeciﬁc culture media (containing tryptic soy broth)
were applied. Clinical and laboratory criteria recommended
by the World Health Organization for the diagnosis of leptospi-
rosis are summarized in Figure 1 [28]. Diagnosis of leptospirosis
requires explicit clinical suspicion of this disease to prompt suf-
ﬁcient testing.
The repeated false-positive HIV screening test performed
with Roche Combo-screening of Case 1 seems remarkable.
Several conditions have been associated with false-positive
results such as pregnancy, autoantibodies, hepatitis, cancer, in-
travenous drug use, and inﬂuenza or rubella vaccination [29–
31]. Weber et al [32] reported false-positive results using
Roche COBAS fourth-generation HIV screening tests at a rate
of 0.41%. False-positive results were found at the highest
Figure 1. Clinical description and recommended case deﬁnition according to the World Health Organization (WHO). Abbreviations: ELISA, enzyme-linked
immunosorbent assay; Ig, immunoglobulin; PCR, polymerase chain reaction.
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frequency in patients with detectable anti-hepatitis A IgM,
pregnant women, and patients suffering from leukemia [32].
To avoid the impact of a false-positive result, repeated testing
using different types of tests and repeated samples for diagnosis
of HIV is mandatory [33]. Our ﬁndings suggest that leptospiro-
sis might also cause false-positive HIV test results.
In case of severe leptospirosis, most physicians will prefer an-
tibiotic treatment because some data showed a decreased dura-
tion of illness with antibiotic therapy [34]. In a Cochrane review,
no signiﬁcant beneﬁt of antibiotic treatment was shown [35].
Case 2 reported a redness, hyperthermia, and swelling of the
distal extremities after application of ceftriaxone. Because her
medical history was positive for a cutaneous reaction after use
of penicillin, an allergic reaction seemed likely. Alternatively, a
Jarisch Herxheimer reaction might have been causative [36].
Jarisch Herxheimer reactions are described for all spirochetal
infections. Administration of antibiotics causes elimination of
spirochetes associated with an acute inﬂammatory response
and release of large amounts of cytokines. Because these symp-
toms occurred in the early course of the disease, ongoing lepto-
spiremia seems possible, which ﬁts for the differential diagnosis
Jarisch Herxheimer reaction.
CONCLUSIONS
Most relevant reservoirs of leptospires worldwide are rodents.
Leptospires are excreted via urine [27, 37] and can survive for
weeks or months in moist soil or water. In this case series, the
reservoir of leptospires might be rodents living along the river.
It is interesting to note that leptospirosis was recently identiﬁed
as cause of death in free-ranging Eurasian beavers (Castor ﬁber)
from the related Aare river [38], thus conﬁrming the presence of
leptospires in the environment and corroborating the river as
probable infectious source. However, although beavers are ro-
dents, they might be only incidental hosts, because they develop
fatal illness. Data on small rodents in Switzerland are scarce.
Only 1 study showed a renal carriage of leptospires at a rate
of 12.6% in small mammals from the city of Zurich [39]. De-
tailed research with serologic testing and PCR of kidney tissue
from beavers, small rodents, and other wildlife species from var-
ious Swiss regions is in progress, to obtain a better picture of the
geographical distribution and prevalence of different Leptospira
sv in potential animal reservoirs. Furthermore, an emergence of
leptospirosis has been observed in domestic dogs, with a major-
ity of recorded cases originating from the Swiss Plateau, includ-
ing the region of the human and beaver cases [40]. Canine
leptospirosis exhibits a high similarity to human disease, for ex-
ample, renal, pulmonary, hemorrhagic, and liver manifestations
are common, and numerous identical sv can cause disease in both
humans and dogs. Therefore, dogs may be considered to be a
model. The emergence of this disease in animals should trigger
a raising awareness of human disease. At the University of Zurich
(Professor Dr. Hatz, Epidemiology, Biostatistics and Preven-
tion Institute), a current research project aims at assessing
the relevance of human leptospirosis in Switzerland. Swiss
hospitals have been contacted to report cases of human lepto-
spirosis diagnosed in the last years and the assumed mode of
acquisition. Based on these data, an estimate of human lepto-
spirosis cases will be gathered that should help to evaluate
trends in human disease. If these data indicated a parallel in-
crease in human leptospirosis, efforts to change the status of
leptospirosis from a nonnotiﬁable to a notiﬁable disease
would be reinforced. Our work strongly supports a cross-species
“One Health” approach with further collaborations between
human and veterinary medicine.
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